Sector Experience

Healthcare
Fortune 500

Experience

Boehringer-Ingelheim Marketing
Senior Associate Director, Pipeline Forecasting
8/2018 - Present
Lead forecasting for major pharmaceutical pipeline. Provide high-level decision support to make go/no-go decisions on preclinical and clinical assets. Created high-impact tools to improve forecasting accuracy.
Selected Contributions:
• Introduced novel stock-and-flow model that correlates tumor biology with commercial viability
• Revamped evaluation process for post-LOE assets in US and EU given the changing biosimilar space

Independent Consulting Services Management Consulting
Lead Consultant
3/2017 - Present
Manage multiple concurrent projects while maintaining exceptional relationships with clients and communicating on key marketing initiatives. Collaborate with clients to define global strategic direction. Drove market research and valuation strategy for repurposed mitochondrial (CNS) rare disease drug in 4 indications.

Quest Diagnostics Marketing
Director, Product Management
8/2011 - 3/2017
Directed all administrative and project support efforts. Conducted in-depth business-development research and compiled results for review by proposal team. Held full P&L accountability for highly-competitive Athena Diagnostics brand, comprising 20-lines of neurological testing and over $80M in revenue. Led cross-functional brand teams across R&D, finance, operations, legal, sales, marketing, and medical affairs on all launches. Developed accounts, KOL, and patient advocates through field travel

Clarion Healthcare Management Consulting
Associate Consultant
7/2006 - 7/2008
Led and participated in teams of up to 8 associates on pharmaceutical industry engagements. Trained over 10 associates in financial analysis and market research, which was the highest-rated new associate training module.

Deutsche Bank Securities Finance
Equity Research Associate
4/2004 - 6/2006
Led teams of up to 3 PhD associates in drafting inter-company and industry reports for over 20 large-and small-cap biotechnology stocks.
Selected Contributions:
• Directed three industry reports receiving prestigious internal award for most differentiated research and thought leadership. Reduced data analysis time by 80% through the use of templates.